Showing results (1-10 of 10,809) with videos related to

Sort By:
Pageof 1,081
Journal of Medicinal Chemistry|July 14, 2023
Phototoxicity─Medicinal Chemistry Strategies for Risk Mitigation in Drug DiscoveryTyler J Harrison, Xin Chen, Kayo Yasoshima, et al.
The Journal of Organic Chemistry|December 17, 2005
An expeditious, high-yielding construction of the food aroma compounds 6-acetyl-1,2,3,4-tetrahydropyridine and 2-acetyl-1-pyrrolineTyler J Harrison, Gregory R Dake
Organic Letters|December 21, 2004
Pt(II) or Ag(I) salt catalyzed cycloisomerizations and tandem cycloadditions forming functionalized azacyclic arraysTyler J Harrison, Gregory R Dake
ACS Medicinal Chemistry Letters|August 16, 2019
Successful Strategies for Mitigation of a Preclinical Signal for Phototoxicity in a DGAT1 InhibitorTyler J Harrison, Daniel Bauer, Alina Berdichevsky, et al.
Journal of Biomedical Optics|December 18, 2014
Consecutively reconstructing absorption and scattering distributions in turbid media with multiple-illumination photoacoustic tomographyPeng Shao, Tyler J Harrison, Roger J Zemp
Journal of the American Chemical Society|April 29, 2011
Toward more "ideal" polyketide natural product synthesis: a step-economical synthesis of zincophorin methyl esterTyler J Harrison, Stephen Ho, James L Leighton
The Journal of Organic Chemistry|May 22, 2004
A modular and concise total synthesis of (+/-)-daurichromenic acid and analoguesHongjuan Hu, Tyler J Harrison, Peter D Wilson
Organic Letters|January 16, 2007
Platinum(II)-catalyzed cyclizations forming quaternary carbon centers, using enesulfonamides, enecarbamates, or enamides as nucleophilesTyler J Harrison, Brian O Patrick, Gregory R Dake
Organic Letters|September 7, 2012
An "aprotic" Tamao oxidation/syn-selective tautomerization reaction for the efficient synthesis of the C1-C9 fragment of fludeloneTyler J Harrison, Philippe M A Rabbat, James L Leighton
Chemical & Pharmaceutical Bulletin|October 6, 2005
Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibitionKentaro Hashimoto, Mikayo Kataoka, Miyuki Tatsuta, et al.
Pageof 1,081